FDA Approves Brexafemme For Recurrent Yeast Infections
The Food and Drug Administration (FDA) has approved Brexafemme (ibrexafungerp) for a second indication for reduction in incidence of recurrent…
Infection prevention
Clinical presentation, diagnosis, and management of Mycoplasma genitalium
In 2015, the Centers for Disease Control and Prevention (CDC) announced that Mycoplasma genitalium was a public health threat.1 Other…
Deadly fungus Candida auris is spreading across US hospitals – a physician answers 5 questions about rising fungal infections
In late March 2023, the U.S. Centers for Disease Control and Prevention highlighted the threat posed by a rapidly spreading…
STD resources for testing, diagnosing and treating sexually transmitted infections
One in five people had a sexually transmitted disease (STD) in 2018, the CDC estimates, adding that the number continued…